Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Vitamin D levels are not linked to alopecia areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Alopecia areata affects quality of life more in adolescents than adults.

AB+ blood group is more common in alopecia areata patients.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Examining hair shape can help predict Alopecia Areata's progression.

People with Alopecia Areata have a higher risk of heart-related health issues.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Immunotherapy can help treat severe alopecia areata.

JAK inhibitors show promise as a future treatment for hair loss.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Upadacitinib effectively treats severe alopecia areata and is safe.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Combining oral methylprednisolone with microneedle radiofrequency improves hair growth in alopecia areata but may cause pain and side effects.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Microneedling can effectively promote hair regrowth in alopecia areata.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

The treatment showed promising hair regrowth in advanced-stage hair loss.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.